Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, February 7, 2023
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
[ Tue, Feb 07th 2023
] - WOPRAI
Joel Beatty Maintained (ARWR) at Buy with Decreased Target to $58 on, Feb 7th, 2023
Joel Beatty of Baird, Maintained "Arrowhead Pharmaceuticals, Inc." (ARWR) at Buy with Decreased Target from $60 to $58 on, Feb 7th, 2023.
Joel has made no other calls on ARWR in the last 4 months.
There are 5 other peers that have a rating on ARWR. Out of the 5 peers that are also analyzing ARWR, 2 agree with Joel's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Andrew Galler of "Morgan Stanley" Maintained at Hold with Decreased Target to $37 on, Tuesday, November 29th, 2022
- Mani Foroohar of "SVB Leerink" Maintained at Hold with Decreased Target to $31 on, Tuesday, November 29th, 2022
These are the ratings of the 3 analyists that currently disagree with Joel
- Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $90 on, Tuesday, December 6th, 2022
- Mayank Mamtani of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $59 on, Wednesday, November 30th, 2022
- Maury Raycroft of "Jefferies" Maintained at Strong Buy with Decreased Target to $75 on, Tuesday, November 29th, 2022
